Monday 1st October | Ivana Sestak, IBIS-II trial statistician, presented at the 2018 American Society for Bone and Mineral Research in Montreal, Canada.  These are the first results reporting bone mineral density changes after stopping anastroxole in a breast cancer prevention participants. 

Thursday 6th September: A new, simple web-based calculator that could better predict the long-term risk of breast cancer returning in other areas of the body has today been published online by researchers at Queen Mary University of London.

Wednesday 2nd May 2018 - UK researchers find that testing for breast and ovarian genetic risk factors is more cost-effective than current family history-based screening if offered to every woman over the age of 30.

Wednesday 2nd May 2018 Professor Jack Cuzick from Queen Mary University of London (QMUL) has received an award for his work on a prognostic test to predict ten year prostate cancer specific mortality 

Tuesday 19 September 2017  Professor Jack Cuzick from Queen Mary University of London (QMUL) has received the Cancer Research UK Lifetime Achievement Award for his work on cancer prevention and detection.

14 Feb 2017 | Guardian Online | Study shows half of GPs are unaware of Tamoxifen for Breast Cancer Prevention

30 Dec 2016 | QMUL | IBIS-II Chair Jack Cuzick appointed CBE in honours from the Queen

03 Dec 2016 | Daily Mail | NICE recommends Anastrozole for breast cancer prevention in high risk women

06 June 2016 | ASCO Press Release | Ten Years of Hormone Therapy Reduces Breast Cancer Recurrence Without Compromising Quality of Life

06 June 2016 | BBC News |  First major trial to see if losing weight reduces the risk of cancers coming back is about to start in the US and Canada

29 April 2016 | QMUL News Story | Dr Cuzick, IBIS Co-Chairman elected as a new Fellow of the Royal Society 

12 Dec 2014 | Medical News Today | Tamoxifen has reduced breast cancer rates 'by a third'

11 Dec 2014 | YouTube | Dr Cuzick on decreasing breast cancer risk with tamoxifen

12 Dec 2014 | The Telegraph | Call for wider use of breast cancer drug

11 Dec 2014 | Cancer Research UK | Tamoxifen protects against breast cancer in long term

11 Dec 2014 | The Pharmaceutical Journal | Chemoprevention with tamoxifen cuts risk of breast cancer by almost 30%

11 Dec 2014 | Los Angeles Times | Breast cancer prevention drug gives lasting protection, study finds

11 Dec 2014 | The Telegraph | Tamoxifen could protect women from cancer for 20 years if taken daily

11 Dec 2014 | The Guardian | Breast cancer drug tamoxifen has long term effect, study finds

13 Dec 2013 | MSNBC | Breast cancer drug to save lives of thousands of women

12 Dec 2013 | King 5 | Study: Hormone-blocker slashes breast cancer risk

12 Dec 2013 | CBS News | Anastrozole reduces breast cancer drug chance by 53 percent, study says

12 Dec 2013 | The Telegraph | 'Remarkable' breast cancer drug could save lives of thousands of women

12 Dec 2013 | ABC News | Drug Halves Breast Cancer Occurrence in Women at High Risk

12 Dec 2013 | Sky News | Breast Cancer Drug 'Halves' Risk In Many

12 Dec 2013 | Daily Mail | Daily pill could HALVE the risk of breast cancer in women with a high risk of the disease 

12 Dec 2013 | The Guardian | Breast cancer drug 'halves likelihood of high-risk women developing disease'

12 Dec 2013 | The Times | Breast cancer drug anastrozole ‘could halve chance of disease’ for high-risk patients

12 Dec 2013 | BBC News | Breast cancer drug 'halves' risk of tumours

21 Feb 2007 | Spirit India | Breast cancer tamoxifen yields long-term reduction in breast cancer risk

21 Feb 2007 | Medical Breakthroughs | Long-lasting Breast Cancer Fighter

21 Feb 2007 | London Evening Standard | Breast cancer drug cuts risk of healthy women getting the disease by 30%

21 Feb 2007 | Wales Online | Tamoxifen could prevent cancer

15 Dec 2007 | PDF Document | Long lasing breast cancer drug offers protection for up to 8 years

8 April 2008 | STV News at six | Top story

2 Sept 2008 | Queen Mary University of London | Study shows postmenopausal women taking anastrozole...

1 July 2011 | Cancer Research UK | Expert opinion: Professor Jack Cuzick

24 April 2013 | BBC Radio 4 | Breast cancer and Tamoxifen

30 April 2013 | The Independent | Hormone drug could dramatically reduce breast cancer risk

30 April 2013 | OnMedica | SERMs ward off common breast cancer over long term

30 April 2013 | Cancer Research UK | Tamoxifen reduces breast cancer by one third

30 April 2013 | Daily Mail Online | Drug prevents breast cancer soon given half million women

30 April 2013 | The Scotsman | Common drugs can reduce breast cancer risk

30 April 2013 | The Telegraph | Breast Cancer Drug Benefits at Risk Patients

15 May 2013 | BBC World News | Angelina's Double Mastectomy - Facts and Issues with Jack Cuzick

15 May 2013 | YouTube | Radical cancer measures - Interview with Jack Cuzick

20 May 2013 | YouTube | IMPAKT 2013: Long-term effectiveness of SERMs for preventing breast cancer

20 May 2013 | YouTube |  Jack Cuzick interview

25 June 2013 | BBC News | NHS to offer tamoxifen to at-risk women

25 June 2013 | The Independent | Tamoxifen and Raloxifene Women to be Offered Daily Pill to Prevent Breast Cancer